Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial (vol 58, pg 729, 2011)

被引：0
|
作者：
Lewis, Edmund J.
机构：
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2012年 / 59卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [1] Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
    Lewis, Edmund J.
    Lewis, Julia B.
    Greene, Tom
    Hunsicker, Lawrence G.
    Berl, Tomas
    Pohl, Marc A.
    de Zeeuw, Dick
    Heerspink, Hiddo Lambers
    Rohde, Richard D.
    Atkins, Robert C.
    Reutens, Anne T.
    Packham, David K.
    Raz, Itamar
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 58 (05) : 729 - 736
  • [2] Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
    Satirapoj, Bancha
    Kaewput, Wisit
    Supasyndh, Ouppatham
    Ruangkanchanasetr, Prajej
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [3] Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria A Randomized, Controlled Trial
    Ito, Sadayoshi
    Kagawa, Tomoya
    Saiki, Takuya
    Shimizu, Kohei
    Kuroda, Shingo
    Sano, Yuhei
    Umeda, Yuusuke
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (03): : 354 - 363
  • [4] Reduction of Microalbuminuria by using Losartan in Normotensive Patients with Type 2 Diabetes Mellitus: a Randomized Controlled Trial
    Agha, Adnan
    Amer, Wasim
    Anwar, Eram
    Bashir, Kaukab
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2009, 20 (03) : 429 - 435
  • [5] Reduction of microalbuminuria in patients with type 2 diabetes - The Shiga Microalbuminuria Reduction Trial (SMART) (vol 30, pg 1581, 2007)
    Tomita, K.
    DIABETES CARE, 2014, 37 (03) : 888 - 888
  • [6] Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus - A randomized clinical trial
    Zandbergen, AAM
    Baggen, MGA
    Lamberts, SWJ
    Bootsma, AH
    de Zeeuw, D
    Ouwendijk, RJT
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (02) : 90 - 96
  • [7] Prevention of microalbuminuria in patients with type 2 diabetes and hypertension (vol 30, pg 811, 2012)
    Menne, J.
    JOURNAL OF HYPERTENSION, 2012, 30 (08) : 1679 - 1679
  • [8] The effect of monomeric and oligomeric FLAVAnols in patients with type 2 diabetes and microalbuminuria (FLAVA-trial): A double-blind randomized controlled trial
    Rashid, Mardin
    Verhoeven, Adrie J. M.
    Mulder, Monique T.
    Timman, Reinier
    Ozcan, Behiye
    Van Beek-Nieuwland, Yvonne
    Chow, Lei M.
    van de Laar, Roel J. J. M.
    Dik, Willem A.
    Sijbrands, Eric J. G.
    Berk, Kirsten A.
    CLINICAL NUTRITION, 2021, 40 (11) : 5587 - 5594
  • [9] A pilot study of the effect of the glycosaminoglycan sulodexide on microalbuminuria in type I diabetic patients (vol 13, pg 539, 1997)
    Szelachowska, M
    Topolska, J
    CURRENT MEDICAL RESEARCH AND OPINION, 1997, 13 (10) : 639 - 639
  • [10] Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial
    Mardin Rashid
    Adrie J. M. Verhoeven
    Monique T. Mulder
    Reinier Timman
    Yvonne van Beek-Nieuwland
    Athumani A. Athumani
    Adrienne A. M. Zandbergen
    Hans E. van der Wiel
    Eric J. G. Sijbrands
    Kirsten A. Berk
    Trials, 19
12345